✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Alpa Laboratories Ltd.

ALPA

Market Cap
₹145 Cr.
P/E
9.67

Alpa Laboratories Ltd.

  • Alpa Laboratories
  • Krebs Biochem.&Inds
  • Panchsheel Organics

FAQs on Alpa Laboratories Ltd. Shareprice

Alpa Laboratories has given better returns compared to its competitors.
Alpa Laboratories has grown at ~4.54% over the last 4yrs while peers have grown at a median rate of -0.77%

Alpa Laboratories is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Alpa Laboratories is 9.67, while 3 year average PE is 12.88.
Also latest EV/EBITDA of Alpa Laboratories is 43.99 while 3yr average is 36.74.

View FAQ's On Business

Growth Table

  • Alpa Laboratories Ltd.
  • Krebs Biochem.&Inds
  • Panchsheel Organics

Balance Sheet

  • Alpa Laboratories Ltd.
  • Krebs Biochem.&Inds
  • Panchsheel Organics

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Alpa Laboratories Ltd.
  • Krebs Biochem.&Inds
  • Panchsheel Organics

Cash Flow

  • Alpa Laboratories Ltd.
  • Krebs Biochem.&Inds
  • Panchsheel Organics

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Alpa Laboratories Ltd.
  • Krebs Biochem.&Inds
  • Panchsheel Organics

Quarterly Results

  • Alpa Laboratories Ltd.
  • Krebs Biochem.&Inds
  • Panchsheel Organics

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Alpa Laboratories Ltd. Financials

Balance sheet of Alpa Laboratories is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Alpa Laboratories is increasing.
Latest net debt of Alpa Laboratories is -₹0.33 Crs as of Mar-26.
This is greater than Mar-25 when it was -₹4.38 Crs.

The profit is oscillating.
The profit of Alpa Laboratories is ₹15.16 Crs for TTM, ₹19.5 Crs for Mar 2025 and ₹16.78 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Alpa Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech